Amanote Research
Register
Sign In
P2.16-15 Toxicities and Survival After Stereotactic Ablative Radiotherapy (SABR) for Centrally Located Lung Tumors
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1490
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
B. Atalar
T. Mustafayev
T. Sio
B. Sahin
G. Gungor
G. Aydin
B. Yapici
E. Ozyar
Publisher
Elsevier BV
Related search
Imaging Follow-Up After Stereotactic Ablative Radiotherapy (SABR) for Lung Tumors
Journal of Radiation Oncology
Oncology
Radiology
Nuclear Medicine
Imaging
MS20.02 the Future of Stereotactic Ablative Radiotherapy (SABR)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.16-15 Kinetic Energy Distribution for Gated Technique at Lung Ablative Body Radiotherapy (SABR)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MTE24.02 Small Lung Tumours: High Risk Lesions and Contraindications to Stereotactic Ablative Body Radiotherapy (SABR)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Population-Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for Up to 5 Oligometastases: SABR-5
BMC Cancer
Cancer Research
Oncology
Genetics
Establishing a Histology-Specific Biologically Effective Dose Threshold for Lung Stereotactic Ablative Radiotherapy (SABR): Is ≥100 Gy10 Enough?
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
P2.16-21 Post-Treatment Survival Difference Between Lobectomy and Stereotactic Ablative Radiotherapy in Stage 1 Non-Small Cell Lung Cancer in England
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Survival and Prognostic Factors for Patients With Advanced Hepatocellular Carcinoma After Stereotactic Ablative Radiotherapy
PLoS ONE
Multidisciplinary
Stereotactic Ablative Radiotherapy for Ultra-Central Lung Tumors: Prioritize Target Coverage or Organs at Risk?
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology